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ABSTRACT 
Two mononuclear copper@11 ibuprofenate adducts with imidaxole or 2-methy~mid~ole and two 
binuclear copper(B) ibuprofenate adducts with metronidaxole or caffeine have been prepared and 
characterized. Elemental analyses, UV-VIS, IR, EPR, and magnetic moment data for imidazole or 
2-methylimidaxole adducts are consistent with mononuclear square planar complexes that contain 
two ibuprofenato ligands and two N-containing imidaxole ligands to give essentially a CuO,N, 
chromophore. The above data for metronidaxole or caffeine adducts are consistent with a 
binuclear structure as found for copperfI1) acetate monohy~a~ and other copperi carboxylate 
dimers. In these complexes four carboxylate groups are bridging two coppedI1) atoms, and two 
added bases coordinated at axial positions to form CuO,N chromophore around each copper. The 
catecholase-mimetic catalytic activities of the complexes have been determined by monitoring the 
formation of o-quinone from catechol. The catalytic activities of the mononuclear complexes are 
lower than those of the binuclear copper(B) ibuprofenate or its metronidaxole or caffeine 
mono-adduce. 
INTRODUC’ITON 
Ibuprofen (2-(4-i~bu~lphenyl~ropionic acid) is a nonstero~al anti~flamma- 
tory drug and has been used for many years in treatment of i~~rnato~ 
diseases. Copper@ complexes of antiinflammatory drugs have been found to be 
more potent and desirable drugs than the parent ligands themselves [l]. Physical 
studies of copper(U) ibuprofenate [2, 31 have shown that it contains binuclear 
units with bridging carboxylate ligands similar to other copper carboxylates[4]. 
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The only known adduct of copper(I1) ibuprofenate is that with pyridine, which 
has been shown to be a mononuclear complex of the type [Cu(O,CR),.L,.H,Ol 
El. 
The coordination chemistry of imidazoles and purines-type ligands have been 
subjected to intensive studies because of the importance of the interactions 
between these ligands and metal ions in many biological system [6]. In addition, 
copper(R) carboxylate adducts with imidazole type ligands have been found to 
have a variety of pharmacological effects such as anticancer [7], superoxide 
dismutase [8], and catecholase mimetic activities [9]. Since nitroimidazoles 
are used as chemotherapeutic agents in the treatment of bacterial infections 
and as radiosensitizers [lo, 111, metronidazole (l-(2-hydroxyethyl)-2-methyl-5- 
nitroimidazole) is used in this study in addition to other ligands, imidazoles, and 
caffeine to form copper(R) ibuprofenate adducts. 
Interest in developing small molecular weight copper@) complexes as model 
copper oxidase enzymes had led to the synthesis of many binuclear and mononu- 
clear copper complexes [9, 12-191; the idea being that these complexes might 
mimic the behavior of various metalloproteins such as the copper containing 
protein tyrosinase. This enzyme is found in many plants and animals and whose 
primary function is to catalyze the oxidation of phenols to o-diphenols (creso- 
lase) and o-diphenols to o-quinones (catecholase) [20]. Recently, we reported 
the synthesis and characterization of several mononuclear copper(I1) carboxyl- 
ates and studied the catecholase mimetic activities of some of these adducts 
[9, 211. We found the dependence of the structure of coppeI(I1) carboxylates 
on the electronic property of the carboxylate groups, and the electronic and 
steric properties of added bases [9, 21-231. In addition, the rate of oxidation of 
catechol to o-benzoquinone by coppel(I1) complexes studied is dependent 
on the nature of nitrogen containing ligands [9, 211. Therefore, structural and 
electronic factors that might impact the properties of copper complexes as 
metalloprotein models are of interest. This article reports the synthesis and 
spectroscopic haracterization of mononuclear and binuclear copper ibupro- 
fenate complexes and examines their catalytic properties in the aerobic oxida- 
tion of catechol to the corresponding o-quinone as models for the catecholase 
function of the copper containing enzyme tyrosinase. 
EXPERIMENTAL 
Reagents and Materials 
All chemicals were of high purity grades (Aldrich or Sigma Chemical Co.) 
and were used without further purification. Tetrakis-p-ibuprofenato dicopper 
(II), [Cu,(Ibup),], (I), (Ibup = ibuprofenato ion) was prepared according to a 
published procedure [2] and recrystallized from anhydrous diethylether and 
dichloromethane (1: 1) 
Preparation of Complexes 
Bidibuprofenato) bis(imidazo1e) copper@), [Cu(Zbup), (Im),], (2). A solution 
of 0.089 g (1.30 mmol) of imidazole in 15 mL methanol was added to 0.303 g 
(0.32 mmol) of Cu,(Ibup),. The mixture was stirred at about 60°C for 1 hr. The 
blue solution was filtered and left in the hood to evaporate. The blue precipi- 
LOPPER COMPLEXES OF IBUPRO~N 257 
tate that formed recrystallized from methanol and air dried. Anal. Calc. for 
C3,H,,N,0,Cu: C, 63.00; H, 6.89; N, 9.19. Found: C, 63.10; H, 7.10; N, 9.25%. 
B~~ibuprofenu?o~ bis(2-met~ylim~azole) copper(H), [Cu~~up~~~2-~irn~~], (3). A 
solution of 0.192 g (2.33 mmol) 2-methylimid~ole in 30 mL methanol was added 
to 0.538 g (0.568 mmol) of C~(Ibup)~. The mixture was stirred at about 60°C for 
1 hr. The blue solution was filtered and left in the hood to evaporate. The bluish 
purple precipitate that formed was washed with anhydrous diethylether and air 
dried. Anal. Calc. for C,H,,N,O&u: C, 64.00; H, 7.21; N, 8.89. Found: C, 
64.15; H, 7.35; N, 8.69%. 
Bis(metronidazole) tetrakis (p-ibuprofenato) dicopper(II), [Cu,(Ibup) (Mtnd),], (4). 
A solution of 0.387 g (2.26 mmol) metronidazole in 50 mL hot absolute ethanol 
was added to 0.523 g (0.552 mmol) of CuJIbup),. The greenish blue solution 
was filtered and left in the hood of evaporate. The green precipitate that 
formed was recrystallized from chloroform and air dried. Anal. Calc. for 
C,,H,,N,O,,Cu,: C, 59.85, H, 6.67; N, 6.52. Found: C, 60.15; H, 6.77; N, 6.65%. 
Bis (caffeine) tetrakis ( p-ibuprofenato) dicopper(ll), [Cu, (Ibup) (Cafnz 1, (5). 
0.458 g (2.36 mmol) caffeine dissolved in 80 mL hot absolute ethanol was added 
to 0.545 g (0.576 mmol) Cu,fIbup), in 20 mL CH,Cl,. The mixture was stirred 
at about 60°C for 3 hr. The greenish blue solution was filtered and left in 
the hood to evaporate. The bluish green precipitate that formed was recrystal- 
lized from CHCl, and the green precipitate was air dried. Anal. Calc. for 
C,H,,NsO,,Cu,: C, 61.12; H, 6.59; N, 8.39. Found: C, 60.94; H, 6.60; N, 8.48%. 
Physical M~urements 
Magnetic sus~ptibili~ measurements at 298 K of powdered samples were 
determined by the Gouy method, with HgCo(NCS), as calibrant, and corrected 
for diamagnetism with appropriate Pascal constants. The effective magnetic 
moment was calculated from the expression: peff = 2.84 (X.T)f. 
Electronic spectra of methanol solutions were obtained with a Bauch and 
Lomb spectronic 2000. Nujol mulls sealed between a ~lyethylene sheet were 
used to obtain IR spectra of the complexes in the 4000 to 200 cm-’ region with 
a Per-kin-Elmer model 843 infrared spectrophotometer. X-band ESR spectra 
of ~lyc~sta~ine material and of methanol/toluene solutions were obtained 
at room temperature and 77 K with an ESPIT-330 Vol.501 spectrometer. 
Diphenylpicrylhydrazide (DPPH, g = 2.0036) was used as the calibrating field 
marker. The catecholase-mimetic activities in air were followed spectrophoto- 
metrically by monito~ng the increase in the o-quinone absorbance at 390 nm as 
a function of time. 0.3 ml of methanol solutions (1 X low3 Ml of the copper 
complexes 2, 3, 4, and 5 or methanol/CH,Cl, (4: 1) in the case of complex 1 
(1 is insoluble in methanol alone) and 2.0 mL of a methanol solution (0.1 M) 
catechol were combined in a 1 cm quartz cell at 298 K and the absorbance 
change at 390 nm is recorded. 
RESULTS AND DISCUSSION 
Magnetic and Spectroscopic Characterization 
The effective magnetic moments and electronic and IR spectral data for 
the copper(B) complexes under investigation are summarized in Table 1. The 
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room temperature magnetic moments for complexes 2 and 3 are in the range 
1.87-1.90 BM. These values are consistent with the presence of one unpaired 
electron in mononuclear copper(I1) complexes. The room temperature magnetic 
moments for complexes 4 and 5 are in the range 1.42-1.45 BM. These sub- 
normal values are lower than the spin-only magnetic moment of 1.73 BM, 
suggesting that coupling between copper atoms occurs. These values are compa- 
rable to the magnetic moment values of binuclear copper(R) carboxylate adducts 
of the type [Cu(RCOO),Ll, [3,41. 
The electronic spectra for the mononuclear adducts 2 and 3 in methanol 
solutions exhibit one broad asymmetric band due to the copperU d-d transi- 
tions (Table 1). The position of the band and the value of its molar absorbitivity 
are in the range expected for mononuclear copper(R) carboxylate adducts ES, 9, 
21-241. The his-adducts, ~(~up)~(Irn)*,2 and ~~~up~2-~rn)~,3 have an 
absorption maximum which is comparable with that found for structurally 
known mononuclear Cu(CXI,COO),(Im), and CulCH&OO),(2-Mim), 121, 22, 
241, and other mononuclear ~ppe~I1) complexes that contain the frans- or 
cis-Cub&O, . . . 0, chromophore [4c, 8,9,21-241. 
The electronic spectra for complexes 4 and 5 obtained in methanol solutions 
exhibit one broad band near 700 nm (Table 1). This band is assigned to the 
copper d-d transitions. These complexes do not show the second band 
(shoulder) at about 37.5 m, the charge transfer band that is characteristic of 
binuclear copper@) adducts with bridging carboxylates [3, 41. This band 
(shoulder) may be obscured by the very intense ligand-to-Mets charge transfer 
band at about 300-330 nm due to the presence of metronidazole or caffeine 
ligands in these binuclear adducts. The position of the band of the copper(R) 
d-d transitions and the magnitude of its molar absorpitivity are comparable 
to those found for binuclear copper carboxylate adducts having bridging 
carboxylate groups and axially coordinated amine ligands [4, 251. 
The assignments of IR frequencies for the antisymmetric v~~,,,(CO~) and 
symmetric, v,,(CO,), stretching vibrations for ibuprofenato group in these 
complexes are given in Table 1. The antisymmetric arboxyl vibration in complex 
3 is not resolved but overlaps with the 2-methylimidazole band to give intense 
and broad absorption band centered at 1565 cm-‘. The positions of the 
v,,,(CO,) and v&CO,) and the separation between them in complexes 2 
and 3 are consistent with a carboxylate group that acts as an unsymmetrical 
TABLE 1. Magnetic Moments and Electronic and IR Spectral and Kinetic Data for the 
Oxidation of Catechol by Cu(II) Complexes 
F,, (BM) h,,,, km) 
~rn~und (298 I0 (e = dm3.moi- ’ cm- ’ ) 
Vasym (CO,) Vsym (COZ) 
km- ‘1 (cm-‘) Activity a 
Ib 1.34 644 1588 1409 0.280 
2 1.90 686 (82) 1595 1395 0.120 
3 1.87 684 (75) 1565 (br)’ 1400 0.065 
4 1.45 700 (320) 1620 1408 0.250 
5 1.42 690 (270) 1618 1410 0.220 
“The activity is reported as micromoles of o-quinone produced per mg catalyst per min. 
‘Ma~etic moment and spectra1 data are taken from Ref. f2l. 
‘br is broad band overlaps with 2-methylimidazole bands. 
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bidentate ligand 121-24, 261. They are comparable to those reported for mono- 
nuclear copper(I1) carboxylate complexes that contain imidazoles having the 
CuN,O* . . . 0, chromophore [9, 21-241. The asymmetric v,,,(CO,) and the 
symmetric v,,(CO,) frequencies for complexes 4 and 5 occur at about 1620 
and 1410 cm-‘, respectively. The positions and the separation between these 
frequencies are similar to those reported for other binuclear copper(I1) car- 
boxylate adducts in which the carboxylate acts as a “bridging” bidentate ligand 
[3, 4b, 261. 
The EPR parameters for the frozen solution and the polycrystalline forms of 
the complexes tudied are summarized in Table 2. A representative frozen EPR 
spectrum of the mononuclear complexes is that of 2 shown in Figure l(A). 
Frozen solution EPR spectra of mononuclear complexes 2 and 3 exhibit 
resolved structure with g,, > g I and are consistent with a tetragonally structure 
[27]. While the g,, regions exhibit Cu hyperfine coupling, the g I regions show 
substantial “N-superhyperfine structure consisting of five equally-spaced peaks. 
The splitting in the g, region is attributed to the presence of two nitrogen 
atoms in the copperiI1) ion plane. Spectral parameters for the mononuclear 
complexes 2 and 3 are comparable to those of previously reported complexes 
that contain essentially the CuN,O, chromophore in a truns or cti square-planar 
arrangement, including those reported for mononuclear bis-adducts of copper(I1) 
carboxylates with imidazoles [8, 9,21-241. These complexes contain a copper(I1) 
atom in a tram or cis arrangement of two ligand nitrogen atoms and one oxygen 
atom from each of the two carboxylate ligands. The second oxygen atom of each 
carboxylate ligand is weakly bonded in a pseudo axial arrangement [21-23, 281. 
Solid-state EPR spectra of 2 and 3 are anisotropic and contain g I and broad g,, 
components. The lack of copper(B) hyperfine coupling in these complexes is 
likely due to dipole-dipole interactions between copper atoms of neighboring 
molecules. 
The EPR spectra for the polycrystalline forms of the binuclear complexes 4 
and 5 were recorded at room temperature. A representative spectrum is that of 
5 shown in Figure l(B). The spectra exhibit three absorption lines typical of 
triplet-state binuclear copper(B) complexes with axial symmetry [3, 4, 253. The 
TABLE 2. EPR data of Copper(B) Ibuprofenate Complexes 
State IDI 
Compound (temperature) g,,” &I g, CxZicZ1) (x$c~-‘) (cm-‘) 
2 Solid 2.138 2.278 2.069 - - - 
(Room) 
Frozen 2.128 2.275 2.055 183 14.7 - 
(77 K) 
3 Solid 2.147 2.314 2.064 - - - 
(Room) 
Frozen 2.142 2.311 2.058 173 14.0 - 
4. 
(77 K) 
Solid 2.217 2.424 2.114 - - 0.368 
(Room) 
5 Solid 2.211 2.419 2.109 - - 0.370 
(Room) 
ag, Values are calculated from the equation g, = i (gn + 2g I ). 
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FIGURE 1. (A) Frozen-solution EPR spectrum of compound 2. (B) solid-state EPR 
spectrum of compound 5 at room temperature. 
EPR parameters were calculated by the method of Wasson et al. [291 by using 
the following equations [4b]: 





where h is the Plank’s constant, Y is microwave frequency, H,, H, are the low 
and the high field parallels, respectively, H, is the perpendicular field, and D is 
the axial zero-field splitting. The parameters g,,, g I , and D values obtained for 
binuclear complexes 4 and 5 are comparable to those found in other binuclear 
coppel(I1) carboxylate adducts [41. 
Catecholase-Mimetic Activity 
Since o-quinone shows a characteristic absorption band at 390 nm, the catalytic 
oxidation of catechol to o-quinone by copper01) complexes can be easily 
followed spectrophotometrically. The change in absorbance at 390 nm versus 
time for the first 15 minutes of the reaction with complexes 1-5 was obtained. 
The activities of these complexes were determined as micromoles of o-quinone 
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produced per mg of catalyst per minute. These values are shown in Table 1. 
Although o-quinone is produced for all complexes, the rate at which it is 
produced varies from binuclear to mononucler catalyst. The rate at which 
o-quinone is produced is also dependent on the nature of the N-~ntaining 
ligand. 
The relatively high catalytic activities of binuclear complexes I, 4, and 
5 compared to mononuclear complexes 2 and 3 (Table 1) is consistent with 
that previously studied which, generally, showed that binuclear copper@) com- 
plexes exhibit catecholase-mimetic activities higher than those of mononuclear 
copper(R) complexes [30]. In tyrosinase and in synthetic copper binuclear 
models, it is believed that two proximate metal atoms are needed to bond to the 
two hydroxyl oxygen atoms of catechols in the oxidation to quinones 114, 311. In 
nonplanar mononucler copper(R) models, it has been proposed that the two 
copper(H) atoms must be located at a distance of less than 5 w for bonding to 
the catechols hydroxyl groups, a mode which should facilitate electron transfer 
to dioxygen [19, 3Oa, 311. The lower catalytic activities of metronidazole and 
caffeine adducts, 4 and 5, respectively, compared to that of the binary complex 
I may be attributed to the presence of these axially coordinated ligands in the 
former adducts. The presence of these ligands could render the approach of 
catechol to copperW) sites more difficult in these two binuclear adducts when 
compared to 1. In addition, the axially coordinated ligands in 4 and 5 are likely 
to dissociate to provide sites on copper for catechol bonding and also to 
facilitate any necessary ligand rearrangement induced by this bonding. Such 
diss~iation is not required in the binary complex I which is axially free. The 
relatively high catalytic activity of 4 compared to 5 may be due to easier 
dissociation of metronidazole ligands in 4 relative to caffeine ligands in 5. The 
dissociation ability of metronidazole may be attributed to the presence of the 
electron ~thdra~ng nitro group in this ligand. The catecholase-mimetic activity 
of the imidazole adduct 2 is higher than that of 2-methy~id~ole adduct 3 
(Table 1). This may be due to steric hindrance caused by the proximity of the 
methyl group to the nitrogen donor atom in 3. The presence of a methyl group 
could render the approach of catechol to copper@) sites more difficult in this 
adduct when compared to the imidazole adduct 2. These results are insistent 
with our previous studies which revealed that the catecholase-mimetic activity of 
mononuclear copper(R) carbovlate adducts with benzimidazole or imidazole is 
higher than those of 2-methyl substituted derivatives [9, 211. 
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